Johannes Schueller

Bevacizumab, Capecitabine, and Oxaliplatin As Neoadjuvant Therapy for Patients With Potentially Curable Metastatic Colorectal Cancer

B. Gruenberger, Dietmar Tamandl, Johannes Schueller et al. · Journal of Clinical Oncology · 2008 · 425 citations · Full text

Medicine, Perioperative Medicine, Surgery +17

Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study

Birgit Gruenberger, Johannes Schueller, Ute Heubrandtner et al. · The Lancet Oncology · 2010 · 244 citations

Medicine, Oncology, Pharmacology +14

Phase III Trial Comparing 4-Day Chronomodulated Therapy Versus 2-Day Conventional Delivery of Fluorouracil, Leucovorin, and Oxaliplatin As First-Line Chemotherapy of Metastatic Colorectal Cancer: The European Organisation for Research and Treatment of Cancer Chronotherapy Group

Sylvie Giacchetti, Georg A. Bjarnason, Carlo Garufi et al. · Journal of Clinical Oncology · 2006 · 227 citations · Full text

Medicine, Oncology, Pharmacology +17

A rapid and simple HPLC assay for quantification of capecitabine for drug monitoring purposes.

André Farkouh, Dagmar E. Ettlinger, Johannes Schueller et al. · PubMed · 2010 · 35 citations

Medicine, Pharmacokinetics, Pharmacology +14

Pharmacokinetics of Darbepoetin Alfa after Intravenous or Subcutaneous Administration in Patients with Non-myeloid Malignancies Undergoing Chemotherapy

Anne C. Heatherington, Christian Dittrich, John T. Sullivan et al. · Clinical Pharmacokinetics · 2006 · 16 citations

Medicine, Pharmacokinetics, Pharmacology +13